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Introduction
Motility is one of the most peculiar functions of the mature
male gamete. In mammalian spermatozoa, the ability to
actively swim, based on the specialized structure of the
flagellum, is acquired during the transit through the epididymis
under the control of different factors, such as cAMP,
intracellular pH, intracellular calcium and phosphorylation of
sperm proteins (Leclerc et al., 1996; Ashizawa et al., 1995;
Vijayaraghavan et al., 1985; Vijayaraghavan et al., 1997a).
Such factors are also involved in the development of a specific
type of motility, called hyperactivation, which occurs as a
consequence of sperm activation in the female genital tract or
by in vitro incubation in various media (Ho and Suarez, 2001).
Sperm protein phosphorylation is regulated by a complex
balance between kinases and phosphatases, which play a
pivotal role in the development and maintenance of motility
(Vijayaraghavan et al., 1997a; Tash and Bracho, 1994). In
particular, the cAMP/PKA-dependent pathway has been
demonstrated to be involved in tyrosine phosphorylation of
different sperm proteins in the flagellum associated to an
increase in sperm motility (Horowitz et al., 1988; Leclerc et
al., 1996; Vijayaraghavan et al., 1997a; Carrera et al., 1996; Si
and Okuno, 1999; Patil et al., 2002; Leclerc and Goupil, 2002;
Ficarro et al., 2003). Both processes are stimulated by cAMP
analogues and through inhibition of serine-threonine
phosphatases by calyculin A (Ashizawa et al., 1995). cAMP
produced by activation of adenylate cyclase binds to PKA
holoenzyme resulting in activation of the catalytic (C) subunit
after dissociation from the regulatory one (R). Multiple
regulatory subunits (RI a and b , RII a and b ) have been
characterized in spermatozoa, although those associated with
the insoluble structures of the sperm flagellum are
predominantly of type II (Lieberman et al., 1988; Horowitz
et al., 1988; Vijayaraghavan et al., 1999), and seem to be
implicated in regulation of sperm motility, at least in humans
(Vijayaraghavan et al., 1997b; Burton et al., 1999). These
regulatory subunits not only modulate PKA serine-threonine
kinase activity, but can also target the catalytic subunit to
different cell compartments by interacting with protein kinase
A-anchoring proteins, AKAPs. Therefore, while cAMP levels
temporally regulate PKA, spatial regulation within the cell
occurs through compartmentalization by binding to AKAP,
thus assuring specificity of PKA function. Since AKAPs
can also simultaneously bind other transduction molecules
including many PKA substrates, they also act as scaffolding
proteins coordinating interactions between different signaling
pathways (Moss and Gerton, 2001). AKAPs possess a variety
of binding affinities for the different subtypes of R isoforms,
1235
Sperm motility is regulated by a complex balance
between kinases and phosphatases. Among them,
phosphatidylinositol 3-kinase (PI 3-kinase) has been
recently suggested to negatively regulate sperm motility
(Luconi, M., Marra, F., Gandini, L., Lenzi, A., Filimberti,
E., Forti, G. and Baldi, E. (2001). Hum. Reprod. 16, 1931-
1937). We demonstrate the presence and activity of PI 3-
kinase in human spermatozoa and have investigated the
molecular mechanism(s) by which the PI 3-kinase inhibitor,
LY294002, triggers an increase in sperm motility. PI 3-
kinase inhibition results in an increase in intracellular
cAMP levels and in tyrosine phosphorylation of the protein
kinase A-anchoring protein AKAP3. These effects finally
result in a stimulation of protein kinase A (PKA) binding
to AKAP3 in sperm tails through the regulatory subunit
RIIb . The increased binding of RII b to AKAP3 induced by
LY294002 is mainly due to tyrosine phosphorylation of
AKAP3, since it is completely blocked by the tyrosine
kinase inhibitor erbstatin, which also reverses the effects of
LY294002 on motility and suppresses PKA-AKAP3
interaction. The requirement of PKA binding to AKAP3
for sperm motility is confirmed by the reduction of motility
induced by an inhibitor of RII b -AKAP3 binding, Ht31,
whose effects on sperm motility and PKA binding to
AKAP3 are reversed by LY294002. 
These results demonstrate that PI 3-kinase negatively
regulates sperm motility by interfering with AKAP3-PKA
binding, providing the first evidence of a molecular
mechanism by which PKA can be targeted to sperm tails
by interaction with tyrosine phosphorylated form of
AKAP3.
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although the molecular mechanisms underlying modulation of
these affinities have still to be elucidated. Yet, the RII binding
domain of different AKAPs is highly conserved among species
(Carrera et al., 1996; Vijayaraghavan et al., 1997b; Moss et al.,
1999; Jha and Shivaji, 2002). 
Among the enzymes involved in regulation of sperm
motility, phosphatidylinositol 3-kinase (PI 3-kinase) has been
recently suggested to play an important role, since its
pharmacological inhibition by LY294002 results in a
significant increase in human sperm forward motility (Luconi
et al., 2001). This family of dimeric enzymes, consisting of a
catalytic (110 kDa) and a regulatory subunit (85 kDa), is
widely expressed in somatic cells and phosphorylates the
inositol ring of different phosphoinositides in position three,
and also stimulates serine-threonine kinases (Wymann and
Pirola, 1998). We have investigated the signaling mechanisms
involved in LY294002 stimulation of human sperm motility
focusing in particular on the AKAP-PKA system. We found
that inhibition of PI 3-kinase results in an increase in
intracellular cAMP levels, in tyrosine phosphorylation of
AKAP and PKA recruitment to sperm tails, providing evidence
for a more general mechanism through which tyrosine
phosphorylation of AKAP may influence PKA recruitment to
specific cell compartments.
Materials and Methods
Antibodies and chemicals
All reagents for human sperm preparation were from Irvine (Santa
Ana, CA, USA). All reagents for sodium dodecyl sulphate-
polyacrylamide gel electrophoresis (SDS-PAGE) were from
Amersham Pharmacia Biotech Italia (Cologno Monzese, Italy). The
conjugated secondary antibodies, protein A- and G-Sepharose and
other not specified reagents were from Sigma Chemical Co (St Louis,
Missouri, USA). Peroxidase-conjugated and unconjugated PY20
antibodies, LY294002, PKA inhibitor H89 and dibutyryl cAMP
(dbcAMP) were obtained from Calbiochem (La Jolla, CA, USA). [ g -
32P]ATP and the RIA kit for cAMP measurement were from NEN
Life Science (Boston, MA, USA). Anti-PI 3-kinase, anti-RII
antibodies and serine/threonine phosphatase activity kit were from
Upstate Biotechnology (Lake Placid, NY, USA). Anti-AKAP3, Ht31
and P-Ht31 were kindly provided by Prof. Daniel Carr (Veteran
Affairs Medical Center, Oregon Health Science University, Portland,
Oregon, USA). Purified PKA regulatory subunit RII a and b were
from Promega (Madison, WI, USA). Anti-ERK2 antibody was kindly
provided by Prof. M. Dunn (Medical College of Wisconsin,
Milwaukee, WI, USA). Anti-FSP95 antibody was kindly provided by
Prof. John Herr (Charlottesville, VA, USA). LY303511 was kindly
provided by Ely Lilli (Indianapolis, IN, USA). 
Preparation of spermatozoa
Human semen was collected in our laboratory according to the WHO
recommended procedure (WHO, 1999) by masturbation from men
undergoing semen analysis for couple infertility caused by a female
factor. All the experiments were performed using samples from these
men who met all the WHO criteria for normozoospermia (WHO,
1999). Samples with leukocytes and/or immature germ cell
concentration greater than 106/ml were not included in the study.
Semen samples were processed by swim up or by minipercoll
techniques as previously described (Krausz et al., 1996). Briefly, for
swim up selection, 1 ml aliquots of semen were gently layered with
1 ml of 1% human serum albumin-HTF (HSA-HTF) medium and
incubated at 37°C, 5% CO2. After 1 hour, 800 m l of the upper medium
phase were collected and checked for sperm count and motility. For
the minipercoll technique, semen samples were layered on top of a
95, 75 and 50% percoll gradient (Pure sperm, Irvine, Santa Ana, CA,
USA) and centrifuged at 500 g for 30 minutes. Only spermatozoa
migrating in the lower phase were collected. After washing,
spermatozoa were incubated for the indicated times with the stimuli.
In some experiments ejaculated spermatozoa were treated with
different stimuli and motility was evaluated according to WHO
manual (WHO, 1999). 
Preparation of sperm tail and head purified fractions was performed
according to the method of Reinton et al. (Reinton et al., 2000) with
slight modifications. Briefly, after washing, treated spermatozoa were
sonicated at 8 burst 3 · 10 seconds in PBS on ice. After 2000 rpm
centrifugation for 5 minutes, supernatant, corresponding to tail
fractions, and pellet, corresponding to head fractions, were checked
under microscope and then extracted in lysis buffer (20 mM Tris,
pH 7.4, 150 mM NaCl, 0.25% NP-40, 1 mM Na3VO4, 1 mM
phenylmethyl-sulforyl fluoride (PMSF). 
Indirect immunofluorescence microscopy of human
spermatozoa
Swim-up-selected human spermatozoa were layered on slides, fixed
in 3.7% formaldehyde, permeabilized in 0.1% Triton X-100 and
subsequently incubated for 2 hours in a humidity chamber at 4°C with
blocking solution (2.5% BSA, 5% goat serum in TTBS; Tris-buffered
saline containing 0.1% Tween 20, pH 7.4) followed by primary anti-
p85 PI 3-kinase antibody revealed by TRITC-conjugated anti-rabbit
secondary antibody (1 hour incubation, room temperature, dilution
1:50 in TTBS). Slides were rinsed with TBS and mounted in a
glycerol:PBS solution (1:9, pH 8.5). Negative controls were
performed by substituting blocking buffer for the primary antibody.
The cells were observed under a Leica immunofluorescence
microscope.
SDS-PAGE and western blot analysis
After the different treatments, sperm samples were processed for
SDS-PAGE as previously described (Luconi et al., 1995). Briefly,
sperm samples, containing about 5 · 106 cells/ml were washed and
resuspended in lysis buffer. After protein measurement (Coomassie
kit, Bio-Rad Laboratories, Hercules, CA, USA), the sperm extracts,
containing approximately 30 m g of protein, were diluted in an equal
volume of 2 · Laemmli’s reducing sample buffer (62.5 mM Tris
pH 6.8, 10% glycerol, 2% SDS, 2.5% pyronin and 200 mM
dithiothreitol), incubated at 95°C for 5 minutes and loaded onto
8% or 10% polyacrylamide-bisacrylamide gels. After SDS-PAGE,
proteins were transferred to nitrocellulose (Sigma Co., St. Louis, MO,
USA). In some experiments, equivalent protein loading was verified
by staining parallel gels with Coomassie R. After blocking in either
5% BSA or skimmed milk for 2 hours in TTBS solution,
nitrocellulose membranes were washed and then immunostained with
primary antibodies followed by the relative peroxidase-conjugated
secondary antibodies. The antibody-reacted proteins were revealed by
the enhanced-chemiluminescence system (BM, Roche, Milan). For re-
probing with different antibodies, the nitrocellulose membranes were
washed for 30 minutes at 50°C in stripping buffer (10 mM Tris, pH
6.8, 2% SDS, 100 mM b -mercaptoethanol) and re-probed with
specific primary antibodies. 
Immunoprecipitation analysis
To evaluate the presence of PI 3-kinase regulatory and catalytic
subunits, about 50 million human spermatozoa, selected by the swim
up technique, were resuspended in lysis buffer followed by
immunoprecipitation. Briefly, after protein measurement, aliquots of
cell lysates containing equal amount of proteins (300 m g) were
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incubated for 1 hour with 30 m l of Protein A-Sepharose (or Protein
G-Sepharose) for preclearing. Precleared lysates were then incubated
for 1 hour using 3 m g of the appropriate primary antibodies (anti-p85
PI 3-kinase regulatory subunit and anti-p110 PI 3-kinase catalytic
subunit, respectively) followed by overnight incubation at 4°C with
50 m l of Protein A-Sepharose. The immunobeads were washed three
times in lysis buffer and then resuspended in 10 m l of 2· reducing
sample buffer and subjected to SDS-PAGE followed by western blot
analysis using anti-p85 PI 3-kinase or anti-p110 PI 3-kinase
antibodies revealed by chemiluminescence. Lysates (300 m g) of a
prostate cancer (PC3) and a mammary cancer (MCF7) cell line were
used as positive controls and immunoprecipitated by the same
protocol.
Immunoprecipitation of AKAP3 was conducted as described
above, using an anti-AKAP antibody. Since AKAP3 is detergent
resistant because of its strong association with the fibrous sheath
compartment, we used an SDS extraction method to lyse spermatozoa
before performing immunoprecipitation (Dr P. Visconti, personal
communication). Briefly, 50 million sperm were extracted inSDS-
SDS-lysis buffer (20 mM Tris-HCl, pH 7.4, 0.2% SDS, 1 mM PMSF)
for 30 minutes. After boiling for 5 minutes at 95°C, samples were
kept for 10 minutes on ice and centrifuged at 12,000 rpm for 5 minutes
at room temperature. Extracted supernatants were then subjected to
AKAP3 immunoprecipitation (see above).
To evaluate the ability of Ht31 and LY294002 to modulate RII b
binding to AKAP3, RII b co-immunoprecipitating with AKAP3 (same
method as for immunoprecipitation, see above) was determined by
western blot analysis using an antibody against RII b .
RII overlay assay 
Protein extracts (50 m g) were separated by 8% SDS-PAGE and
transferred to nitrocellulose membranes as described above. RII
binding to AKAP3 present in those extracts was investigated as
previously described, by a modified western blot procedure, called
overlay assay (Vijayaraghavan et al., 1997b; Rosenmund et al., 1994).
Nitrocellulose membranes were incubated overnight in a blotto
solution (Tris-buffered saline, pH 7.4, 5% milk, 0.1% BSA)
containing purified RII a or RIIb (200 ng/ml). After washing, bound
RII was detected by western blot analysis using antibodies against
respectively RII a or b followed by peroxidase-conjugated secondary
antibodies revealed by chemiluminescence.
PI 3-kinase assay
Sperm samples treated as indicated, were extracted with lysis buffer
A (20 mM Tris, pH 7.4, 137 mM NaCl, 1 mM CaCl2, 1 mM MgCl2,
1% NP-40, 1 mM Na3VO4, 1 mM PMSF). After measurement of
proteins, aliquots of sperm extracts containing equivalent amount of
proteins (300 m g) were incubated for 1 hour with 50 m l of Protein G-
Sepharose for preclearing. Precleared lysates were then incubated for
1 hour using 3 m g of rabbit anti-p85 PI 3-kinase (# 06-195, Upstate
Biotechnology, Lake Placid, NY) on ice followed by overnight
incubation at 4°C with 50 m l of Protein A-Sepharose. Sepharose beads
were washed twice in lysis buffer and twice with a 10 mM Tris-HCl
(pH 7.4) containing 0.1 mM EGTA and 5 mM LiCl. At the last wash,
all beads were divided into two groups: one quarter (1:4) was
subjected to western blot analysis with the same antibody used for
immunoprecipitation, to ensure that protein G pulls down the same
amount of the enzyme in all samples. The remaining three-quarters
(3:4) were suspended in kinase buffer (10 mM Tris-HCl, 150 mM
NaCl, 5 mM EDTA) containing 20 m g of L- a -phosphatidylinositol
(Sigma Chemical Co, St. Louis, Missouri, US) 25 mM MgCl2 and 10
m Ci of [g -32P]ATP and incubated for 20 minutes at room temperature.
The reaction was stopped by the addition of 60 m l of 6 M HCl and
160 m l of a mixture of chloroform and methanol (1:1) were added.
Lipids were then resolved by thin layer chromatography plates (TLC
silica gel 60) (Merck Laborchimica, Florence, Italy) in chloroform,
methanol, water and ammonium hydroxide (60:47:11,3:2). Dried TLC
sheets were developed by autoradiography. Quantifications of the
bands were performed using a Kodak image analysis system.
Intracellular cAMP levels 
Sperm samples (4· 106 cells) treated with 10 m M LY294002 for 1 up
to 15 minutes, were washed twice in PBS and extracted overnight in
absolute ethanol at –20°C. Intracellular cyclic AMP levels were
evaluated by a RIA kit (NEN Life Science, Boston, MA) in
supernatants after centrifugation (1000 g, 10 minutes), lyophilization
and reconstitution in 0.05 M sodium acetate buffer, pH 6.2 (Belen
Herrero et al., 2000). Experiments were carried out in duplicate and
results expressed as percentage of stimulation over control, taken as
100%. 
Evaluation of sperm motility and viability
Motility was evaluated by computer assisted semen analysis (CASA,
Hamilton Thorn Research, Beverly, MA, US). The settings used
during CASA procedure were: analysis duration of 1 second (30
frames); minimum contrast, 80; minimum size, 3; low size and high
size gates, 0.7 and 2.6; low intensity and high intensity gates, 0.34
and 1.40 (Luconi et al., 2001). All measurements were performed at
37°C. Motility was expressed as forward (type a+b motility, according
to WHO manual, 1999) and rapid (type a motility, according to WHO
manual, 1999).
Sperm viability was evaluated under a phase contrast light using
the Eosin technique or the hyposmotic swelling test according to
WHO manual (WHO, 1999).
Statistical analysis
Data are expressed as means ± s.e.m.. Statistical analysis was
performed with ANOVA and Student’s t-test for unpaired and, when
applicable, for paired data.
Results
Presence and activity of phosphatidylinositol 3-kinase
(PI 3-kinase)
Although the presence of PI 3-kinase in human spermatozoa
has been indirectly demonstrated by the use of inhibitors such
as wortmannin and LY294002 (Luconi et al., 2001; Fisher et
al., 1998), there has been no direct evidence of its presence and
activity, so far. Thus, we performed immunoprecipitation of
both regulatory and catalytic subunits from total lysates of
capacitated human spermatozoa. As shown in Fig. 1A,B, both
PI 3-kinase subunits are present in human spermatozoa
migrating in SDS-PAGE at the expected molecular mass as in
the positive controls (MCF7 cells, for p85 regulatory subunit
and PC3 cells, for p110 catalytic subunit, respectively). PI 3-
kinase specific activity was evaluated as the ability of the
catalytic subunit, co-immunoprecipitated using a polyclonal
antibody against p85, to phosphorylate phosphatidylinositol
(PtdIns) in an in vitro kinase assay. As shown in Fig.  1C, PI
3-kinase activity in human sperm is inhibited by the treatment
of sperm with 10 m M LY294002. An aliquot of the p85
immunoprecipitate was subjected to western blot analysis with
the same antibody used for immunoprecipitation, to ensure that
protein G pulls down the same amount of the enzyme in both
samples (Fig.  1D). In order to investigate the precise cellular
localization of PI 3-kinase, we performed western blot analysis
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with the antibody against the p85 regulatory subunit on purified
sperm tail and head fractions. As shown in Fig. 2A, the
regulatory subunit is mainly localized in sperm tails, although
a weak positivity is also found in the heads after long exposure
of the film, as confirmed by immunofluorescence analysis
using the same antibody on fixed and permeabilized
spermatozoa (Fig.  2B, b). No staining was present in sperm
tails in the negative control (Fig. 2A, a).
In order to demonstrate that the stimulatory effect induced
by LY294002 on sperm forward motility (Luconi et al., 2001)
is caused by specific inhibition of PI 3-kinase, we compared
the effects of LY294002 with those of the inactive analogue
LY303511 (Vlahos et al., 1994). Direct addition of LY303511
to swim up-selected spermatozoa does not affect the
percentage of forward sperm motility (Table 1), suggesting that
the increase in motility induced by LY294002 is due to a
specific inhibition of PI 3-kinase activity.
Involvement of cAMP and tyrosine phosphorylation of
sperm proteins in mediating LY294002 stimulatory effect
on motility
In order to elucidate the molecular mechanism by which
inhibition of PI 3-kinase leads to stimulation of sperm motility,
we investigated the two main intracellular signaling pathways
involved in regulation of sperm motility, namely cAMP and
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Fig. 1. Presence and activity of PI 3-kinase in human
spermatozoa. Immunoprecipitation of (A) p85
regulatory subunit and (B) p110 catalytic subunit of
PI 3-kinase from human sperm lysates and of MCF-7
or PC3 cells, respectively, as positive controls.
Immunobeads obtained with anti-p85 PI 3-kinase or
anti-p110 PI 3-kinase antibodies (IP) were separated
by 8% SDS-PAGE and the transferred proteins were
revealed by western blotting with the same
antibodies used for immunoprecipitation (IB).
Molecular mass markers are indicated on the right
(A) and on the left (B) of the blots. (C) PI 3-kinase
activity in sperm samples treated or not with 10 m M
LY294002 was evaluated by in vitro assay after
immunoprecipitation with anti-p85 antibody. The
spots correspond to PI 3-kinase catalytic product
[32P]phosphatidylinositol phosphate (PiP).
Representative of four similar experiments.
(D) Aliquot (1:4) of the p85 immunoprecipitates
were subjected to western blot analysis with the
same antibody, to ensure that protein G pulls down
the same amount of the enzyme in both samples.
Total lysates from PC3 cells and spermatozoa were
run as positive controls. 
Fig. 2. Intracellular localization of PI 3-kinase in human
spermatozoa. (A) Western blot analysis of tail and head protein
extracts from swim-up-selected spermatozoa separated onto 8%
SDS-PAGE and transferred to a nitrocellulose membrane. The
membrane was first blotted with anti-p85 PI 3-kinase regulatory
subunit antibody (upper panel). Anti-ERK2 antibody (lower panel)
was used to check for equal lane loading after stripping and re-
probing of the same membrane. MCF7 cell lysate was used as
positive control. Molecular mass markers are indicated on the right
of the blot. Representative of two similar experiments.
(B) Immunofluorescence analysis of fixed and permeabilized human
spermatozoa probed with the antibody against the anti-p85 regulatory
subunit of PI 3-kinase (b). Negative control avoiding the primary
antibody is shown in a, whereas the respective fields observed in
light transmission microscopy are reported in c and d. Arrows
indicate sperm heads. Representative of four similar experiments.
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tyrosine phosphorylation of sperm proteins (Leclerc et al.,
1996; Vijayaraghavan et al., 1997a; Carrera et al., 1996; Si and
Okuno, 1999; Patil et al., 2002; Leclerc and Goupil, 2002). As
shown in Fig.  3A, LY294002 stimulates a rapid and significant
increase in intracellular cAMP levels in swim-up-selected
spermatozoa after 1 and 5 minutes of incubation. The increase
in cAMP is transient and declines to basal levels after 10
minutes of incubation, compared to control. Intracellular
cAMP levels in basal condition in swim-up-selected
spermatozoa were 13.0±4.4 pmol/107 spermatozoa (n=18).
Fig.  3B shows the effect of the cAMP analogue dibutyryl
cAMP (dbcAMP) and of LY294002 on swim-up-selected and
unselected spermatozoa. The two compounds stimulate a
similar increase in sperm motility, without any synergic effect,
suggesting that both compounds act on the same signaling
pathway (Fig. 3B). 
Since an increase in cAMP levels has been described to be
associated with an increase in tyrosine phosphorylation of
sperm proteins (Leclerc et al., 1996; Vijayaraghavan et al.,
1985; Vijayaraghavan et al., 1997a; Leclerc and Goupil, 2002),
we next evaluated the effect of LY294002 on the latter process.
Western blot analysis of sperm lysates using PY20-HRP
antibody shows that stimulation of swim-up-selected
spermatozoa with LY294002 for 1 hour dose-dependently
stimulates tyrosine phosphorylation of a sperm protein of about
110 kDa (Fig.  4A). An increase in tyrosine phosphorylation
of a p110 kDa sperm protein band is already present after 1-
minute stimulation with LY294002 (Fig.  4B), but, while the
increase in cAMP levels is transient (Fig.  3A), the one in
tyrosine phosphorylation appears to be long lasting. In view of
such rapid effects of LY294002 on intracellular signal
transduction events, we evaluated whether the stimulatory
effect on sperm motility was also present at early times. As
shown in Table 2, the effect of LY294002 on both forward and
rapid motility is already present after a 3-minute stimulation
and lasts for a long time. The involvement of tyrosine
phosphorylation of sperm proteins in mediating LY294002
effects on sperm motility is also confirmed by the results
obtained with erbstatin, a potent tyrosine kinase inhibitor.
Indeed, as previously demonstrated (Luconi et al., 1995;
Luconi et al., 1996), incubation of swim-up-selected
spermatozoa with erbstatin reduces sperm forward motility and
tyrosine phosphorylation of sperm proteins. In the presence of
erbstatin (1 hour) the positive effects of LY294002 (10 m M) on
sperm motility are totally suppressed (Fig. 5A). This effect is
only partially due to a toxic effect of erbstatin, since after 2-
hour incubation only a slight decrease in sperm viability is
observed (percentage of viability: control, 89.1±1.4; erbstatin
25 m g/ml, 70.6±6.0; erbstatin 12.5 m g/ml, 70.3±9.0, n=6;
respectively 21.4% and 20.0% for viability decrease versus
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Fig. 3. (A) Time-dependent effect of LY294002 on intracellular
cAMP levels in swim-up-selected human spermatozoa. After
different times of incubation with LY294002 (10 m M), sperm
samples were washed and extracted in ethanol. Intracellular cAMP
concentrations were evaluated by a RIA kit as described in Materials
and Methods. Data represent means±s.e.m. from eight different
experiments. *P<0.01, **P<0.001 versus control. Student’s t-test for
paired data. (B) Effects of dbcAMP and LY294002 on sperm
motility. Swim-up-selected sperm samples were incubated for 1 hour
in the presence of dbcAMP (1 mM) or LY294002 (10 m M) alone or
in combination and forward and rapid motility was evaluated by
CASA. Data represent means±s.e.m. from five different experiments.
The percentage of sperm forward motility for swim-up-selected
spermatozoa is indicated on the left ordinate, whereas the right
ordinate indicates the same parameter for unselected spermatozoa.
*P<0.001 versus respective controls, Student’s t-test for paired data.
Table 1. Effect of addition of LY294002 or LY303511 to
swim up selected spermatozoa on sperm forward motility 
% Forward motility Control LY294002 LY303511 
Swim up 61.8±4.3 77.6±5.9* 65.0±5.1
Sperm forward motility (type a+b motility, according to WHO criteria,
WHO, 1999) was evaluated by CASA in swim-up-selected spermatozoa
incubated for 1 hour in the presence of LY294002 (10 m M) or LY303511
(10 m M). Data represent means±s.e.m. of sperm forward motility in 10
different samples. 
*P<0.001 versus control. Student’s t-test for paired data.
Table 2. Time-dependent effect of LY294002 on sperm
motility in swim-up-selected human spermatozoa 
% Motility 3 minutes 10 minutes 60 minutes
Forward Control 63.1±5.6 68.1±3.0 62.1±4.2
LY294002 76.7±5.8* 79.4±2.4* 78.0±3.3*
Rapid Control 45.4±8.1 48.6±7.0 43.8±7.8
LY294002 55.7±8.5* 63.9±5.9* 57.07±6.4*
Percentage sperm forward and rapid motility (type a+b and a motility
respectively, according to WHO criteria; WHO, 1999) was evaluated by
CASA in swim-up-selected spermatozoa incubated for different times in the
presence of LY294002 (10 m M). Data represent means±s.e.m. of 13 different
experiments. 
*P<0.001 vs respective control, Student’s t-test for paired data.
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74.3% and 58.9% for motility decrease). Western blot analysis
of protein extracts using PY20 antibody as probe shows that
erbstatin also inhibits LY294002-stimulated increase in
tyrosine phosphorylation of the p110 kDa protein band (Fig.
5B). 
LY294002 induces an increase in tyrosine
phosphorylation of AKAP 3 in sperm tails
To characterize the nature of the 110 kDa band which is
tyrosine phosphorylated following LY294002 stimulation (Fig.
4A,B; Fig. 5B), we performed western blot analysis of sperm
lysates using a polyclonal antibody against AKAP3 [anti-
AKAP3 antibody (Vijayaraghavan et al., 1999)]. This protein,
of about 110 kDa molecular mass, belonging to the wide family
of protein kinase A anchoring proteins (AKAPs), has been
recently described in human spermatozoa as a scaffolding
protein associated with the fibrous sheath of the flagellum, and
is involved in regulation of sperm motility (Vijayaraghavan et
al., 1999; Moss and Gerton, 2001). Since AKAP3 localizes
predominantly in sperm tails, we performed western blot
analysis of purified tail fractions from human spermatozoa
treated or not with LY294002. Fig.  6A confirms that AKAP3
is present in human sperm tails, as previously described
(Vijayaraghavan et al., 1999). The stripping and re-probing of
the same membrane with PY20 antibody reveals an increase in
tyrosine phosphorylation in response to LY294002 in a p110
kDa protein band co-migrating with AKAP3 (Fig. 6B) on the
same gel. The apparent increase in AKAP3 immunoreactivity
observed in the lysates of spermatozoa treated with LY294002
(Fig.  6A) is evident in all the experiments (not shown)
performed using the antibody against the human AKAP3 (see
also Fig.  6D and Fig.  11B), although normalization of the
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Fig. 4. Dose- and time-dependent effects of PI 3-kinase inhibition on
tyrosine phosphorylation of sperm p110 kDa protein. Western blot
analysis of sperm lysates from swim-up-selected spermatozoa
stimulated for 1 hour with increasing concentrations of LY294002
(LY, A), or treated with 10 m M LY294002 for the different times
indicated (B) were separated by 8% SDS-PAGE. Equal amounts
(30 m g) of sperm proteins were subjected to 8% SDS-PAGE.
Tyrosine phosphorylated proteins were revealed with PY20-HRP
antibody. C, control at 10 minutes. Molecular mass markers are
indicated on the right of the blots. Arrowheads indicate the
modulated band at about 110 kDa. Representative of three similar
experiments. 
Fig. 5. Tyrosine phosphorylation of sperm p110 kDa protein
mediates LY294002 stimulatory effects on motility. (A) Effects of 1
hour treatment with LY294002 (LY, 10 m M) in the presence or
absence of the tyrosine kinase inhibitor erbstatin (E, 12.5 or 25
m g/ml) on both forward and rapid motility of swim-up-selected
spermatozoa. Sperm forward motility and rapid motility was
evaluated by CASA. Data represent means±s.e.m. of five different
experiments. #P<0.01 and *P<0.001 versus respective control,
°P<0.001 versus respective LY; Student’s t-test for paired data.
(B) Western blot analysis of sperm lysates from swim-up-selected
spermatozoa stimulated for 1 hour with 10 m M LY294002 and
erbstatin (E, 12.5 or 25 m g/ml) together or alone. Equal amount
(30 m g) of sperm proteins were subjected to 8% SDS-PAGE.
Tyrosine phosphorylated proteins were revealed in
chemiluminescence with PY20-HRP antibody. Molecular mass
markers are indicated on the right of the blots. Arrowhead indicates
the p110 kDa protein. Representative of five different experiments. 
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blots with an unrelated antibody directed against a constitutive
protein such as extracellular signal-regulated regulated kinase
2 (Luconi et al., 1998), ERK2, does not reveal any difference
in the protein loading (Fig.  11D). Since spermatozoa are
transcriptionally and transductionally inactive, we speculate
that the observed increase in AKAP3 positivity in the presence
of LY294002 may be due to a stronger reaction of the anti-
AKAP3 antibody with the tyrosine phosphorylated form of the
protein. This hypothesis is also supported by the apparent
decrease in AKAP3 immunoreactivity in western blot analysis
in the presence of erbstatin (Fig. 11B). On the other hand, a
different antibody directed against AKAP3, anti FSP95
antibody (Mandal et al., 1999), does not reveal any increase in
protein positivity in a 110 kDa band upon treatment with
LY294002 (Fig.  6C, see also Fig.  11C), while such an increase
was present when the same membranes were probed with the
anti-AKAP3 antibody (Fig.  6D and Fig.  11B). 
In order to further demonstrate that the 110 kDa protein
undergoing tyrosine phosphorylation in response to LY294002
stimulation is AKAP3, we immunoprecipitated the protein
with anti-AKAP3 antibody from spermatozoa treated or not
with LY294002 (Fig.  7A,B). Western blot analysis using PY20
antibody as probe shows a marked increase in tyrosine
phosphorylation of AKAP3 immunoprecipitated from
LY294002 treated samples (Fig.  7A,B, upper panels). The
stripping and re-probing of the same membrane with anti-
AKAP3 (Fig.  7A, lower panel) and with anti-FSP95 (Fig.  7B,
lower panel) antibodies shows that the anti-AKAP3 antibody
pull down the same amount of proteins and that both anti-
AKAP3 and anti-FSP95 antibodies do recognize the same
protein (Vijayaraghavan et al., 1999; Mandal et al., 1999). The
absence of any increase in AKAP3 positivity in LY294002-
treated sample versus control using anti-AKAP3 antibody in
western blot after immunoprecipitation (Fig.  7A), may be due
to the AKAP3 extraction method used for immunoprecipitation
compared to the simple lysis buffer used for western blot
analysis (Fig.  6A and Fig. 11B).
The increase in tyrosine phosphorylation in AKAP
results in tail recruitment of PKA through interaction with
RIIb
Western blot analysis of purified sperm tail and head fractions
using specific antibodies against the regulatory RIIb (Fig.  8A)
and the catalytic (Fig.  8B) subunits of PKA shows that both
subunits are localized in both sperm tails and heads and that
their positivity is increased in the former compartment
following treatment of sperm with LY294002 (Fig.  8A,B). 
To demonstrate that the observed increase of RIIb positivity
in sperm tails following LY294002 stimulation (Fig.  8B) is
due to an increased binding to AKAP3, we used Ht31, a
pharmacological disruptor of this interaction (Vijayaraghavan
et al., 1997b). Incubation of swim-up-selected spermatozoa
with Ht31 results in a significant inhibition of both forward and
rapid motility of sperm, which is totally prevented by
LY294002 (Fig. 9A). The inactive inhibitor, P-Ht31, used
as negative control, is ineffective (Fig. 9A). By interfering
with PKA-AKAP interaction through RII b , Ht31 induces
Fig. 6. LY294002-induced tyrosine phosphorylation of AKAP3.
(A,B) Western blot analysis of tail protein extracts from swim-up-
selected spermatozoa treated or not with 10 m M LY294002,
separated on 10% SDS-PAGE and transferred to a nitrocellulose
membrane. The membrane was first blotted with anti-AKAP3
antibody (A) and, after stripping, re-probed with anti-
phosphotyrosine antibody, PY20-HRP (B). (C,D) Western blot
analysis of total protein extracts from swim-up-selected spermatozoa
treated or not with 10 m M LY294002. Twenty m g of sperm lysates
were run in duplicate onto 8% SDS-PAGE and transferred to
nitrocellulose membrane. The membrane was cut longitudinally in
two parts that were probed with anti-FSP95 (C) and anti-AKAP3 (D)
respectively. Molecular mass markers are indicated on the right of
the blots. Representative of three similar experiments.
Fig. 7. Western blot analysis of immunoprecipitated AKAP3
from spermatozoa treated or not with 10 m M LY294002. After 1-
hour treatment, sperm samples were extracted in SDS buffer (see
Materials and Methods). Cells lysates were immunoprecipitated
(IP) using an anti-AKAP3 antibody, electrophoresed on 8%
SDS, and immunoblotted with anti-phosphotyrosine antibody
(IB: PY20-HRP, upper panels), stripped and re-probed with anti-
AKAP3 antibody (IB: AKAP3, A, lower panel) or anti-FSP95
antibody (IB: FSP95, B, lower panel). Molecular mass markers
are indicated on the right of the blots. Representative of three
similar experiments. 
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the release of the PKA regulatory subunit from the insoluble
fraction of sperm proteins to the soluble fraction, as
demonstrated in bovine spermatozoa (Vijayaraghavan et al.,
1997b). In western blot analysis of insoluble protein extracts
from swim-up-selected human spermatozoa treated or not with
10 m M LY294002, anti-RII b antibody reveals an increase of
RIIb following LY294002 stimulation both in the presence and
absence of Ht31 (Fig. 9B, upper panel). 
Co-immunoprecipitation experiments in which sperm
protein extracts immunoprecipitated for AKAP3 were revealed
in western blot analysis with anti-RII b antibody to detect the
amount of RII b bound to AKAP3, show that LY294002
increases the interaction between AKAP3 and RII b , as
demonstrated by the increased amount of RII b co-
immunoprecipitated with AKAP3 in LY-stimulated samples
(Fig.  9C). Moreover, the concomitant presence of LY294002
partially reverses Ht31 reduction in RII binding, demonstrating
that LY294002 overcomes the inhibition exerted by Ht31 on
AKAP3-RIIb binding. 
To further demonstrate that the binding of RII b to AKAP3
is increased by LY294002 in our cell system, we performed
RII overlay assay on protein extracts from swim-up-selected
spermatozoa treated or not with 10 m M of the inhibitor.
RII overlay assay demonstrates that following LY294002
stimulation there is an increase in the binding of RII b to
AKAP3 (average fold increase: 2.3±0.3 LY294002 vs basal,
n=5), but not of the RII a isoform (Fig.  10A,B). Stripping and
reprobing the same membrane using anti-phosphotyrosine
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Fig. 8. Effect of LY294002 on localization of PKA regulatory and
catalytic subunits in sperm tails and heads. Western blot analysis of
tail and head protein extracts from swim-up-selected spermatozoa
treated or not with 10 m M LY294002, separated onto 10% SDS-
PAGE and transferred to a nitrocellulose membrane. The membrane
was blotted with antibodies against RIIb (A) and PKA catalytic (B)
subunits. Anti-ERK2 antibody (C) was used to check for equal lane
loading after stripping and re-probing of the same membrane. Jurkat
cells have been used as positive controls for PKA subunits.
Molecular mass markers are indicated on the right of the blots.
Representative of three similar experiments.
Fig. 9. Effects of Ht31 on LY294002-stimulated increase in
sperm motility, RIIb localization and interaction with
AKAP3 in spermatozoa. (A) Swim-up-selected spermatozoa
were incubated for 1 hour in the presence of LY294002
(10 m M) with or without the active inhibitor Ht31 (10 m M)
or the inactive molecule P-Ht31 (10 m M) and sperm forward
and rapid motility was evaluated by CASA. Data represent
means±s.e.m. of seven different experiments. *P<0.01 and
**P<0.001 versus respective controls, #P<0.001 versus
Ht31, Student’s t-test for paired data. (B) Western blot
analysis of insoluble protein extracts from swim-up-selected
spermatozoa treated or not with 10 m M LY294002 in the
presence or absence of 10 m M Ht31. Insoluble protein
fractions separated by 8% SDS-PAGE and transferred to a
nitrocellulose membrane were revealed first with anti-RIIb
antibody (upper panel) and, after stripping, with anti-ERK2
antibody to check for equal lane loading (lower panel).
Human endothelial cells were used as positive control.
Molecular mass markers are indicated to the right of the
blot. Representative of three similar experiments.
(C) Effects of Ht31 and LY294002 on RIIb -AKAP3
interaction as revealed by co-immunoprecipitation of RIIb
with AKAP3. Swim-up-selected spermatozoa treated with
Ht31 or LY294002 alone or in combination were extracted
in immunoprecipitation buffer containing 0.1% SDS and
immunoprecipitated with anti-AKAP3 antibody (see
Materials and Methods). After 8% SDS-PAGE of the
immunobeads, proteins transferred to nitrocellulose
membranes were revealed with anti-FSP95 (upper panel) or
anti-RII b (lower panel) antibodies. Molecular mass markers
are indicated on the left of the blot. Representative of two
similar experiments. 
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PY20 (Fig.  10C) confirms the increase in tyrosine
phosphorylation of AKAP3 following LY294002 treatment. 
To gain insight into whether the increase in tyrosine
phosphorylation of AKAP3 stimulated by LY294002 is
involved in AKAP binding to RII b , we incubated spermatozoa
with 25 m g/ml erbstatin for 1 hour and evaluated RII b binding
to AKAP3 by overlay assay. As shown in Fig.  11A, sperm
treatment with erbstatin completely abolishes binding of RII b
to AKAP3 both in basal condition and in the presence of
LY294002 (10 m M), suggesting that tyrosine phosphorylation
is necessary for AKAP3-RIIb interaction. After stripping, the
same membranes were subsequently subjected to western blot
analysis using anti-AKAP3 (Fig.  11B) and anti-FSP95 (Fig.
11C) to reveal the protein band interacting with RII b .
Finally, the role of PKA activation in mediating LY294002
stimulatory effect on sperm motility was investigated by using
the PKA inhibitor H89. Treatment of swim-up-selected
spermatozoa with 50 m M H89 reduces not only basal but also
LY294002 and dbcAMP-stimulated motility to a similar extent
(Fig. 12). However, the effect of the two compounds was still
present in the presence of H89. This result suggests that,
although PKA activation is necessary for both LY294002 and
dbcAMP stimulation of sperm motility, the two compounds
may act on multiple points on the cAMP/PKA pathway, as also
demonstrated by their effect on tyrosine phosphorylation of
sperm proteins (these results) (Leclerc et al., 1996; Bajpai and
Doncel, 2003).
Discussion
We have demonstrated that: (i) PI 3-kinase is present and active
in human spermatozoa; (ii) pharmacological inhibition of PI 3-
kinase by LY293002, previously shown to increase sperm
motility (Luconi et al., 2001), induces a significant increase in
intracellular cAMP levels and tyrosine phosphorylation of the
PKA anchoring protein AKAP3; (iii) the increase in tyrosine
phosphorylation of AKAP3 is necessary for PKA binding
through recruitment of its regulatory subunit RII b in sperm
tails.
Although the presence of PI 3-kinase in human spermatozoa
has been previously suggested by indirect studies employing
pharmacological inhibitors such as wortmannin and LY294002
(Luconi et al., 2001; Fisher et al., 1998), direct evidence for
its presence and activity has not been available. By
immunoprecipitation, western analysis and
immunofluorescence microscopy, we show here that both
catalytic and regulatory subunits of the enzyme are present in
human spermatozoa and that p85 mainly localizes in sperm
Fig. 10. RII overlay assay (A,B) and western blot analysis (C,D) of
protein extracts from swim-up-selected spermatozoa treated or not
with LY294002. After treatment with 10 m M LY294002, sperm
samples were lysed and proteins were separated by 8% SDS-PAGE
and transferred to nitrocellulose membranes. RII overlay assay: For
RII overlay assay, membranes were first incubated with purified RII a
(A) or RIIb (B) PKA regulatory subunits followed by probing with
anti-RII a (A) or anti-RIIb (B) antibodies. After stripping, the same
membrane was subsequently subjected to western blot analysis using
PY20 antibody (C) and, finally, anti-ERK2 antibody (D) to check for
equal protein loading (IB: western blot analysis). Arrowheads in A-C
indicate the AKAP3, which is tyrosine phosphorylated following
LY294002 incubation and which binds PKA RII regulatory subunits.
Molecular mass markers are indicated on the right of the blots.
Representative of three similar experiments. 
Fig. 11. Effect of inhibition of tyrosine phosphorylation of proteins
by erbstatin on functional binding of RII b to AKAP3 in human
spermatozoa. Sperm proteins from spermatozoa treated with
LY294002 (LY, 10 m M) or erbstatin (E, 25 m g/ml) alone or together
for 1 hour, were separated by 8% SDS-PAGE and transferred to a
nitrocellulose membrane. (A) RIIb overlay assay: the membrane was
incubated with purified RII b subunit followed by probing with anti-
RIIb antibody revealed by chemiluminescence. After stripping, the
same membrane was subsequently probed with anti-AKAP3 (B, IB:
AKAP3) and anti-FSP95 (C, IB: FSP95) antibodies. Arrowheads in
A-C indicate the AKAP3, which is tyrosine phosphorylated
following LY294002 incubation and which binds RII b regulatory
subunits. Anti-ERK-2 antibody was used to check for equal protein
loading (D, IB:ERK-2). Molecular mass markers are indicated on the
right of the blots. Representative of three similar experiments.
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tails. Immunokinase assay also shows that PI 3-kinase is active
in human spermatozoa and is inhibited by LY294002. In
addition, results of functional experiments demonstrating that
LY294002, but not its inactive analogue LY303511, is able to
increase sperm forward motility, provide evidence for the
involvement of PI 3-kinase in regulation of this sperm function. 
Increases in cAMP levels and protein phosphorylation are
the main intracellular events involved in regulation of sperm
motility (Leclerc et al., 1996; Vijayaraghavan et al., 1985;
Vijayaraghavan et al., 1997a; Carrera et al., 1996; Si and
Okuno, 1999; Patil et al., 2002; Leclerc and Goupil, 2002;
Ficarro et al., 2003). We show here that inhibition of PI 3-
kinase by LY294002 induces a rapid increase in both
intracellular cAMP levels and tyrosine phosphorylation of
AKAP3, a protein kinase A-anchoring protein that is mostly
found in sperm tails. Both processes are associated with a rapid
and sustained increase in sperm forward motility. The non-
synergic stimulatory effect on sperm motility exerted by
LY294002 and dbcAMP strongly suggests that both
compounds converge on the same signaling pathway of PKA
activation. In agreement with our findings, inhibition of PI 3-
kinase by LY294002 has been recently demonstrated to
increase cyclic nucleotide-dependent excitation signaling in
olfactory receptor neurons (Spehr et al., 2002). 
Tyrosine phosphorylation of AKAP3 stimulated by
LY294002 seems to be mediated by activation of sperm
tyrosine kinases, since it is completely blocked by the tyrosine
kinase inhibitor erbstatin, which also blocks the effects of
LY294002 on sperm motility. LY294002 stimulation of
tyrosine phosphorylation of AKAP3 is associated with an
increased binding between AKAP3 and PKA as well as with
a recruitment of both PKA regulatory and catalytic subunits to
the sperm tail compartment (Fig.  8B). Since both RIIb binding
to AKAP3 and sperm forward motility are inhibited by
treatment with the tyrosine kinase inhibitor erbstatin, tyrosine
phosphorylation of AKAP3 seems to be necessary for its
interaction with PKA. The involvement of increased PKA-
AKAP3 interaction in the stimulatory effect of LY294002 on
sperm motility is further substantiated by the ability of this
compound to reverse the detrimental effect of Ht31 on motility
(Fig.  9A). This compound, which has a hydrophobic sequence
homologue to AKAP, has been widely demonstrated to disrupt
RII binding to the anchoring protein, both in vitro, by overlay
assay (Vijayaraghavan et al., 1997b; Carr et al., 1991; Carr et
al., 1992) and NMR analysis (Newlon et al., 1999), and, in
vivo, by fluorescence resonance energy transfer techniques
(Ruehr et al., 1999). We show here that LY294002 is able to
stimulate both RIIb recruitment to the sperm insoluble
compartment (Fig.  9B) and RII b binding to AKAP3 also in
the presence of Ht31 (Fig.  9C), resulting in maintenance of
sperm motility (Fig.  9A). 
An increase in tyrosine phosphorylation during sperm
capacitation has been previously described not only for
AKAP3 (Vijayaraghavan et al., 1999; Mandal et al., 1999;
Naaby-Hansen et al., 2002) but also for other members of the
AKAP family, such as AKAP4 (Carrera et al., 1996), which
localizes specifically to the fibrous sheath of the principal piece
of sperm tail and shows high identity with AKAP3. Our study
shows that tyrosine phosphorylation of AKAP3 determines an
increased binding of RII b , resulting in tail recruitment of PKA
and increase of sperm motility, providing evidence for a
functional role of tyrosine phosphorylation of AKAP3. PKA
binding to tyrosine-phosphorylated AKAP3 is specifically
mediated by RIIb and not by the a isoform, suggesting
that PKA activation is regulated not only by specific
compartmentalization of the enzyme, but also by binding of
different regulatory isoforms to the scaffolding proteins.
Although the possible dual specificity nature of AKAP3 for
both regulatory subunits type I and II has not yet been
investigated, many AKAPs have been shown to possess a
higher affinity for RII regulatory subunit than for RI (Burton
et al., 1997). Thus, AKAP binds PKA-specific regulatory
subunits to drive the holoenzyme to a defined compartment,
allowing the catalytic subunit to interact with its substrates.
The rapid and transient increase in intracellular cAMP levels
induced by LY294002 in sperm suggests that PI 3-kinase
inhibition not only results in the recruitment of PKA to sperm
tails through tyrosine phosphorylation of AKAP3, but may also
contribute to locally activate PKA. In fact, inhibition of PKA
activity by H89, interferes with LY294002 stimulation of
sperm motility. Whether AKAP-PKA interaction is also
important for sperm PKA activation remains to be investigated.
However, a recent report by Furusawa (Furusawa et al., 2002)
demonstrated that disruption of AKAP-PKA interaction in
HeLa cells results in suppression of PKA activation. 
Despite several attempts to elucidate the role of different
components of the PKA holoenzyme in regulation of sperm
motility, it is not yet clear which regulatory subunit is
important for sperm motility. In human sperm, disruption of
RII b interaction with AKAP3 dramatically inhibits motility
(Vijayaraghavan et al., 1997b; Harrison et al., 2000), in
agreement with our data. Conversely, in the mouse, deletion
of RII a gene delocalizes the PKA catalytic subunit from the
Journal of Cell Science 117 (7)
0
10
20
30
40
50
60
70
80
90
%
 S
pe
rm
 F
or
w
ar
d 
M
ot
ili
ty
H89 50 m M
C LY dbcAMP
LY+dbcAMP
C LY dbcAMP
LY+dbcAMP
  #
 #  #
*# *# *#
§
Fig. 12. Effect of PKA inhibition by H89 on sperm forward motility
of swim-up-selected spermatozoa stimulated with LY294002 and
dbcAMP. Swim-up-selected sperm samples were incubated for 1
hour in the presence of dbcAMP (1 mM), LY294002 (10 m M) and
H89 (50 m M) alone or in combination, and forward and rapid
motility were evaluated by CASA. Data represent means±s.e.m. of
five different experiments. *P<0.01 versus respective stimulus with
H89 and #P<0.01 versus respective controls (C) with or without
H89; §P<0.01 versus C without H89; Student’s t-test for paired data.
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insoluble to the cytosolic fraction, without, however,
affecting sperm motility and fertilizing ability (Burton et al.,
1999). However, the same group has recently reported that
knockout mice for PKA a catalytic subunit show a
concomitant decrease in RII a and b contents associated with
a significant decrease in sperm forward motility, despite
normal spermatogenesis (Skalhegg et al., 2002), thus
suggesting a major role of PKA in regulation of sperm
motility. These discrepancies may be due to species
differences or may suggest a major role of RII b rather than
a in modulating sperm motility. In this scenario, it is possible
that disruption of AKAP3-PKA interaction, as a result of
defects in the intracellular signaling (AKAP tyrosine
phosphorylation) described in the present study, may account
for alterations in sperm motility associated with male
infertility. Tyrosine phosphorylation of AKAP3 might also
regulate binding of other proteins probably involved in
regulation of sperm motility, such as the recently described
ropporin and AKAP-associated protein (Carr et al., 2001).
The importance of AKAP scaffolding proteins in regulating
sperm motility has been very recently brought to light by the
finding that targeted disruption of the Akap4 gene, whose
product AKAP4 is close related to AKAP3, causes defects in
sperm flagellum and motility in the mutant mice (Miki et al.,
2002).
In conclusion, our data provide a novel molecular model
according to which tyrosine phosphorylation of AKAP3,
induced by inhibition of PI 3-kinase, stimulates a recruitment
of PKA through its regulatory subunit RII b to the sperm tail,
resulting in an increase of sperm motility. Tyrosine
phosphorylation of AKAPs may represent a more general
mechanism for modulation of their affinity for different
PKA regulatory subunits and other interacting proteins, thus
leading to recruitment of these proteins to different cellular
compartments.
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